Alan B. Lancz & Associates, Inc. 23and Me Holding Co. Transaction History
Alan B. Lancz & Associates, Inc.
- $94.4 Million
- Q4 2023
A detailed history of Alan B. Lancz & Associates, Inc. transactions in 23and Me Holding Co. stock. As of the latest transaction made, Alan B. Lancz & Associates, Inc. holds 12,300 shares of ME stock, worth $5,904. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,300
Previous 14,900
17.45%
Holding current value
$5,904
Previous $14,000
21.43%
% of portfolio
0.01%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding ME
# of Institutions
161Shares Held
122MCall Options Held
197KPut Options Held
229K-
Black Rock Inc. New York, NY21.6MShares$10.3 Million0.0% of portfolio
-
New View Capital Partners I, LLC Burlingame, CA19.5MShares$9.34 Million8.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.3MShares$7.83 Million0.0% of portfolio
-
Euclidean Capital LLC New York, NY10.2MShares$4.92 Million0.7% of portfolio
-
Geode Capital Management, LLC Boston, MA7.48MShares$3.59 Million0.0% of portfolio
About 23andMe Holding Co.
- Ticker ME
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 259,768,000
- Market Cap $125M
- Description
- 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...